Anteris Technologies Global Corp.
Business
Anteris Technologies Global Corp. develops the DurAVR® THV System, a balloon-expandable transcatheter aortic valve using proprietary ADAPT® anti-calcification tissue technology to treat aortic stenosis. The company is advancing its lead product through the PARADIGM Trial, a global pivotal study, with regulatory approvals obtained in Europe and the United States. Anteris targets North American and European markets and operates as a development-stage medical device company with manufacturing partnerships.
Summary from 10-K filed 2026-02-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| Net sales | 2 | 3 | |
| Cost of products sold | −569,000 | −1 | |
| Research and development expense | −69 | −51 | |
| Selling, general and administrative expense | −26 | −28 | |
| Operating loss | −94 | −78 | |
| Other non-operating income, net | 467,000 | 2 | |
| Interest and amortization of debt discount and expense | −73,000 | −47,000 | |
| Net foreign exchange (losses)/gains | −744,000 | 1 | |
| Debt issuance costs | 0 | −465,000 | |
| Loss on debt extinguishment | 0 | −904,000 | |
| Fair value movement of derivatives | 19,000 | −61,000 | |
| Loss before income taxes from continuing operations | −94 | −76 | |
| Income tax (expense)/benefit | 0 | 0 | |
| Loss after income tax | −94 | −76 | |
| Non-controlling interests | −81,000 | 324,000 | |
| Stockholders of the Company | −94 | −76 | |
| Basic loss per share (in Dollars per share) | −2.55 | −3.68 | |
| Diluted loss per share (in Dollars per share) | −2.55 | −3.68 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Cash, cash equivalents and restricted cash | 13 | 70 | 21 | |
| Accounts receivable from customers, net of allowances | 32,000 | 208,000 | — | |
| Inventories | 152,000 | 513,000 | — | |
| Prepaid expenses | 642,000 | 640,000 | — | |
| Other current assets | 2 | 3 | — | |
| Total Current Assets | 16 | 75 | — | |
| Plant and equipment, net | 5 | 5 | — | |
| Operating lease right-of-use assets, net | 2 | 1 | — | |
| Intangible assets, net | 65,000 | 189,000 | — | |
| Total Non-Current Assets | 7 | 6 | — | |
| TOTAL ASSETS | 23 | 81 | — | |
| Accounts payable | 11 | 6 | — | |
| Accrued and other liabilities | 10 | 10 | — | |
| Current portion of operating lease liabilities | 566,000 | 747,000 | — | |
| Current portion of debt obligations | 16,000 | 3,000 | — | |
| Total Current Liabilities | 21 | 17 | — | |
| Operating lease liabilities | 2 | 645,000 | — | |
| Long-term debt obligations | 22,000 | — | — | |
| Other liabilities | 177,000 | 812,000 | — | |
| Total Non-Current Liabilities | 2 | 1 | — | |
| TOTAL LIABILITIES | 23 | 18 | — | |
| COMMITMENTS AND CONTINGENCIES | — | — | — | |
| Common Stock, $0.0001 par value, 400,000,000 shares authorized, 41,579,881 and 35,939,816 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 4,000 | 4,000 | — | |
| Preferred stock, $0.0001 par value, 40,000,000 shares authorized | 0 | 0 | — | |
| Additional paid in capital | 381 | 350 | — | |
| Accumulated other comprehensive loss | −10 | −11 | — | |
| Accumulated deficit | −371 | −276 | — | |
| TOTAL STOCKHOLDERS EQUITY | −93,000 | 63 | — | |
| Non-controlling interests | −160,000 | −79,000 | −403,000 | |
| TOTAL EQUITY (DEFICIT) | −253,000 | 63 | 19 | |
| TOTAL LIABILITIES AND EQUITY | 23 | 81 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| Depreciation and amortization expense | 2 | 2 | |
| Equity-settled stock-based compensation | 8 | 7 | |
| Debt issuance costs | 0 | 465,000 | |
| Other items | −29,000 | 78,000 | |
| Accounts receivable, prepayments and other assets | −515,000 | −911,000 | |
| Inventories | 362,000 | −71,000 | |
| Accounts payable, accrued and other liabilities | 6 | 8 | |
| NET CASH USED IN OPERATING ACTIVITIES | −78 | −61 | |
| Acquisition of plant and equipment | −2 | −2 | |
| Acquisition of intangible assets | 0 | −14,000 | |
| Deferred proceeds from sale of distribution rights | 1 | 0 | |
| NET CASH USED IN INVESTING ACTIVITIES | −596,000 | −2 | |
| Net proceeds from share issues | 26 | 120 | |
| Share issue transaction costs | −3 | −4 | |
| Tax withholding paid on stock option exercises | −1 | 0 | |
| Proceeds from issuance of convertible notes | 0 | 5 | |
| Repayment of debt | −1 | −7 | |
| Debt issuance costs paid | 0 | −465,000 | |
| Cash settlement of contingent options on debt | 0 | −191,000 | |
| Principal payments on finance lease obligations | −14,000 | −9,000 | |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 21 | 113 | |
| Effect of exchange rate movements on cash, cash equivalents and restricted cash | −38,000 | 57,000 | |
| Net change during the year | −58 | 49 | |
| Cash received for research and development tax incentive | 594,000 | 962,000 | |
| Operating cash outflows relating to operating leases | −969,000 | −834,000 | |
| Non-cash additions to right-of-use assets and lease liabilities | 2 | 295,000 | |
| Non-cash issue of shares/warrants to consultants for services provided | 735,000 | 430,000 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Anteris Technologies Global Corp.'s CIK number?
Anteris Technologies Global Corp.'s SEC CIK number is 0002011514 (2011514). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Anteris Technologies Global Corp.'s SEC filings?
All of Anteris Technologies Global Corp.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Anteris Technologies Global Corp. last report earnings?
Anteris Technologies Global Corp. (AVR) most recently filed an earnings 8-K with the SEC on May 13, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001140361-26-020896). This is Anteris Technologies Global Corp.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Anteris Technologies Global Corp.'s most recent earnings 8-K?
Anteris Technologies Global Corp.'s latest earnings 8-K (Item 2.02) was filed May 13, 2026 under accession 0001140361-26-020896. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Anteris Technologies Global Corp.'s latest earnings 8-K →
Look up any company's CIK number →